Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of JNJ-38518168 in adults with uncontrolled eosinophilic persistent asthma
2012-004920-39Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma and eosinophilic asthma (EA) comparing JNJ-38518168 with Placebo (2 arms). Primary endpoint: Change from baseline in prebronchodilator percent-predicted forced expiratory volume in 1 second. Started Apr 2013; status: completed.
02
Drugs
toreforant
03
Conditions
asthmaeosinophilic asthma (EA)
Beyond the preview
Go deeper on 2012-004920-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004920-39.